z-logo
Premium
Fetal urinary insulin‐like growth factor I and binding protein 3 in bilateral obstructive uropathies
Author(s) -
Bussieres L.,
Laborde K.,
Souberbielle J. C.,
Muller F.,
Dommergues M.,
Sachs C.
Publication year - 1995
Publication title -
prenatal diagnosis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.956
H-Index - 97
eISSN - 1097-0223
pISSN - 0197-3851
DOI - 10.1002/pd.1970151110
Subject(s) - obstructive uropathy , medicine , oligohydramnios , urinary system , renal function , urology , creatinine , fetus , endocrinology , insulin like growth factor , pregnancy , growth factor , biology , receptor , genetics
Fetal urinary concentrations of insulin‐like growth factor I (UIGF‐I) and binding protein 3 (UIGFBP‐3) were determined in patients with prenatal diagnosis of bilateral obstructive uropathy. Patients were retrospectively assigned to three groups, on the basis of outcome: group 1, termination of pregnancies ( n = 11) with sonographic evidence of severe oligohydramnios or renal dysplasia, confirmed at histological examination; group 2, patients ( n = 10) with postnatal plasma creatinine > 50 μmol/1 at the age of 1 year (1 yr‐pCreat); and group 3, patients ( n = 16) with 1 yr‐pCreat ≤ μmol/1. The results show a significant increase in UIGF‐I and UIGFBP‐3 in groups 1 (18 159 ± 9083 pg/ml; 2657 ± 669 ng/ml) and 2 (1574 ± 847 pg/ml; 176 ± 50 ng/ml) in comparison with group 3 (35 ± 6 pg/ml; 21 ± 2 ng/ml). UIGF‐I and UIGFBP‐3 were significantly correlated with postnatal plasma creatinine, and were both sensitive (90 per cent; 80 per cent) and specific (88 per cent; 88 per cent) for prediction of elevated 1 yr‐pCreat (>50 μmol/1). Fetal urinary IGF‐I and IGFBP‐3 are increased in severe fetal bilateral obstructive uropathy, possibly reflecting tubular dysfunction or/and increased synthesis consequent upon fetal kidney injury. Their predictive value for postnatal renal function needs further assessment.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here